He loves to love this company. They hang in through any cycle. They have to make sure they get the professional market right and wonders if Amazon may be making it tougher. The valuation is still in line with 10 year historical. He would continue to own it.

He is wondering what their strategy is going to be over the next five years. The business is very mature and he thinks it will require another capex cycle. He wouldn’t step in right now. He would keep watching it for now.

He hasn’t evaluated the fundamentals lately, but he sees them continue to meet earning calls. It looks okay right now and likes the sharp corrective move lately as it feels more bullish. It has a loft valuation, but would continue to give it rope.

The problem is that following a multi-decade interest rate decline, a rise in interest rates going forward will impact this as it is viewed as a bond proxy. It is an interest rate issue. This is not the time to step in right now.

They have a good cash float, which will lead to a share buyback, he feels. He sees resistance at $90-$100, which will be tough to battle through. He would suggest taking a loss if you hold this one, because the future capex requirements will be more expensive as interest rates rise. He would prefer IHI-N if you like the healthcare space as he does.

This is the best of the financial sector stocks, he feels. It has a great dividend and strong balance sheet. If the macro economies do well it will too. They can do buybacks and trades at 1.75 to book value. He thinks national credit provisions for losses will be a key sell signal – when they tighten, get out. Yield 2%.

They have instituted a share buyback and took a beating on earnings. Storm clouds are starting to form in the space. He thinks further selling could be coming soon.